Mankind Pharma Assigned 64.8 ESG Rating by SES

Mankind Pharma Limited has submitted a regulatory disclosure to BSE Limited and the National Stock Exchange of India Limited regarding an Environmental, Social, and Governance (ESG) rating assignment.

The disclosure is made pursuant to Regulation 30 & 51 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("Listing Regulations").

SES ESG Research Private Limited ("SES"), a SEBI registered ESG Rating Provider, has assigned the company an ESG Rating of '64.8'. The rating was assigned for FY26 and was based solely on publicly available information. The company clarified that it did not engage SES for this rating, meaning the assessment was independently initiated and conducted by the rating provider.

The disclosure was made available on the company's website at www.mankindpharma.com.

The letter was digitally signed by Hitesh Kumar Jain, Company Secretary & Compliance Officer, on November 5, 2026, at 13:19:46 IST.

Financial Impact

Financial impact not quantified in the disclosure.